Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 86.30
-4.50 (-4.96%)
At close: Mar 4, 2026
NSE:ARISTO Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Net Income | 36.79 | 40.63 | 38.96 | 35.62 | 14.34 | 10.76 | Upgrade
|
| Depreciation & Amortization | 27.83 | 26.02 | 15.71 | 15.36 | 10.99 | 7.49 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.69 | - | 0 | - | - | - | Upgrade
|
| Other Operating Activities | 16.03 | 16.01 | 16.48 | 26.98 | 25.36 | 25.47 | Upgrade
|
| Change in Accounts Receivable | -121.02 | 12.89 | -129 | -113.73 | -4.35 | 155.4 | Upgrade
|
| Change in Inventory | -11.09 | -71.79 | -94.1 | -64.15 | 75.83 | -76.21 | Upgrade
|
| Change in Accounts Payable | -46.58 | 89.08 | 241.08 | 101.78 | -31.39 | 5.42 | Upgrade
|
| Change in Other Net Operating Assets | 178.47 | -12.67 | -13.13 | -29.7 | -23 | -105.49 | Upgrade
|
| Operating Cash Flow | 81.11 | 100.17 | 76 | -27.84 | 67.78 | 22.84 | Upgrade
|
| Operating Cash Flow Growth | -17.81% | 31.79% | - | - | 196.75% | 62.34% | Upgrade
|
| Capital Expenditures | -36.99 | -51.07 | -65.55 | -40.61 | -32.49 | -19.89 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.69 | 2.31 | 0.2 | 2.68 | 0.04 | - | Upgrade
|
| Investment in Securities | - | - | - | -0.08 | - | - | Upgrade
|
| Other Investing Activities | -5.37 | -3.02 | 0.46 | 0.56 | 0.84 | 0.12 | Upgrade
|
| Investing Cash Flow | -41.2 | -51.47 | -66.1 | -37.46 | -31.6 | -19.78 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 13.89 | Upgrade
|
| Long-Term Debt Repaid | - | -23.56 | -1.7 | -9.25 | -9.69 | - | Upgrade
|
| Net Debt Issued (Repaid) | -7.02 | -23.56 | -1.7 | -9.25 | -9.69 | 13.89 | Upgrade
|
| Issuance of Common Stock | - | - | - | 130.52 | - | - | Upgrade
|
| Common Dividends Paid | -3.4 | -3.4 | -4.43 | - | - | - | Upgrade
|
| Other Financing Activities | -16.48 | -16.95 | -15.95 | -41.61 | -23.45 | -21.08 | Upgrade
|
| Financing Cash Flow | -26.9 | -43.91 | -22.07 | 79.66 | -33.14 | -7.19 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 13.01 | 4.78 | -12.16 | 14.37 | 3.04 | -4.13 | Upgrade
|
| Free Cash Flow | 44.12 | 49.1 | 10.45 | -68.44 | 35.29 | 2.95 | Upgrade
|
| Free Cash Flow Growth | 52.80% | 369.65% | - | - | 1097.18% | - | Upgrade
|
| Free Cash Flow Margin | 1.22% | 1.54% | 0.43% | -3.14% | 2.13% | 0.18% | Upgrade
|
| Free Cash Flow Per Share | 6.48 | 7.21 | 1.54 | -12.91 | 7.07 | 0.59 | Upgrade
|
| Cash Interest Paid | 18.93 | 18.09 | 16.67 | 22.07 | 18.82 | 22.09 | Upgrade
|
| Cash Income Tax Paid | 13.49 | 14.41 | 13.87 | 12.62 | -3.5 | 3.45 | Upgrade
|
| Levered Free Cash Flow | -130.77 | -25.12 | 31 | -76.52 | -9.32 | -32.38 | Upgrade
|
| Unlevered Free Cash Flow | -119.73 | -13.81 | 41.43 | -62.72 | 2.44 | -18.57 | Upgrade
|
| Change in Working Capital | -0.23 | 17.5 | 4.86 | -105.8 | 17.1 | -20.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.